Juha Lindner

Juha Lindner, PhD, currently serves as the Director and Global R&D Program Management Lead at BioNTech SE, focusing on mRNA-based individualized cancer vaccines developed in collaboration with Genentech. With previous experience at Roche as a Global Program & Portfolio Manager and Senior Biomarker Experimental Medicine Scientist in Oncology, Juha has contributed significantly to various antibody development programs. Prior roles include Associate Director at MorphoSys AG, where project leadership was provided for bispecific antibody development, and Sr. Project Manager at Immatics, leading efforts in peptide-based cancer vaccines. Juha's academic credentials include a PhD in Molecular Virology and Immunology from the University of Regensburg, along with additional certifications in Leadership in Drug Development and Intercultural Competence.